#for_researcher

Biomarkers for physical frailty and sarcopenia

R. Calvani, F. Marini, M. Cesari, et al.

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

This review provides an overview of currently available biological markers for PF and sarcopenia, as well as a critical appraisal of strengths and weaknesses of traditional procedures for biomarker development in the field. A novel approach for biomarker identification and validation, based on multivariate methodologies, is also discussed.

 

English

Physical frailty and sarcopenia (PF&S): a point of view from the industry

S. Del Signore and R.Roubenff

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

We agree with regulators that better characterization of subpopulations, not only in elderly patients, can improve the benefit risk ratio of medicines. At the same time, we believe it is in the public health interest to develop novel drugs indicated for specific geriatric conditions.

English

Possibilities of ICT-supported services in the clinical management of older adults

M. Vollenbroek-Hutten, S. Jansen-Kosterink, M. Tabak, et al.

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

Aim of this article is to describe the possible field of application for ICTsupported services in the management of older adults, in particular those with functional impairment.

English

The need of operational paradigms for frailty in older persons: the SPRINTT project

M. Cesari, E. Marzetti, R. Calvani, et al.

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

The lack of consensus around a single operational definition has limited the clinical implementation of frailty in clinical practice.

In this context, the recently funded “Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies” (SPRINTT) project (largely based on such a novel approach) may indeed fill an important gap in the field and provide key insights for counteracting the disabling cascade in the elderly.

English

Preventing mobility disability in Europe: a health economics perspective from the SPRINTT study

N. Sirven, T. Rapp, S. Coretti, et al.

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

The “Sarcopenia and Physical fRailty IN older people: multicomponenT Treatment strategies” (SPRINTT) project will provide a unique opportunity to explore health economics issues associated with frailty.

English

Physical frailty, sarcopenia, and the enablement of autonomy: philosophical issues in geriatric medicine

A. Blasimme

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

In this paper, I show that what in political and moral philosophy has come to be known as “the capability approach” may indeed provide much needed conceptual clarification in the area of frailty research.

English

The “Sarcopenia and Physical fRailty IN older people: multicomponenT Treatment strategies” (SPRINTT) randomized controlled trial: design and methods

F. Landi, M. Cesari, R. Calvani, et al.

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

SPRINTT is a phase III, multicenter RCT aimed at comparing the efficacy of a MCI, based on long-term structured physical activity, nutritional counseling/dietary intervention, and an information and communication technology intervention, versus a healthy aging lifestyle education program designed to prevent mobility disability in 1500 older persons with physical frailty and sarcopenia who will be followed for up to 36 months.

 

English

Rationale for a preliminary operational definition of physical frailty and sarcopenia in the SPRINTT trial

M. Cesari, F. Landi, R. Calvani, et al.

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

In the present article, the rationale that guided the operationalization of the theoretical concept of physical frailty and sarcopenia (PF&S), the condition of interest for the “Sarcopenia and Physical Frailty in Older People: Multicomponent Treatment Strategies” (SPRINTT) trial, is presented.

English

Prevalence and Incidence of Frailty in Community-Dwelling Older People: Beijing Longitudinal Study of Aging II

Z. Zheng, S. Guan, H. Ding, et al.

J Am Geriatr Soc. 2016;64(6):1281-6

The objective of this secondary analysis of a prospective cohort study was to estimate the prevalence and incidence of frailty and evaluate the effect of frailty on adverse outcomes in 10,039 Chinese elderly adults (≥55 years). A 12.3% prevalence and a 13% incidence of frailty was demonstrated in community-dwelling Chinese older adults.
English

Pages

Subscribe to RSS - #for_researcher